We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

120 hedge funds and large institutions have $542M invested in IVERIC bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 39 increasing their positions, 28 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

403% more call options, than puts

Call options by funds: $8.43M | Put options by funds: $1.68M

106% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 18

39% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 28

27% more capital invested

Capital invested by funds: $426M → $542M (+$116M)

19% more funds holding

Funds holding: 101120 (+19)

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

Holders
120
Holders Change
+19
Holders Change %
+18.81%
% of All Funds
2.12%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.11%
New
37
Increased
39
Reduced
28
Closed
18
Calls
$8.43M
Puts
$1.68M
Net Calls
+$6.75M
Net Calls Change
+$3.51M
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
26
Stonepine Capital Management
Oregon
$5.53M -$10M -1,562,240 -66%
Goldman Sachs
27
Goldman Sachs
New York
$5.51M +$2.88M +450,211 +130%
FCM
28
Farallon Capital Management
California
$5.21M
Morgan Stanley
29
Morgan Stanley
New York
$4.74M +$4.16M +649,375 +1,802%
OCA
30
Octagon Capital Advisors
New York
$4.7M +$4.35M +680,036 New
Deutsche Bank
31
Deutsche Bank
Germany
$4.48M +$3.58M +558,853 +626%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.37M +$574K +89,743 +36%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$1.94M -$32.6K -5,100 -2%
First Trust Advisors
34
First Trust Advisors
Illinois
$1.39M -$57.3K -8,954 -4%
Charles Schwab
35
Charles Schwab
California
$1.39M -$410 -64 -0%
AG
36
Algert Global
California
$1.39M -$75.1K -11,740 -6%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$1.31M +$445K +69,500 +58%
Wells Fargo
38
Wells Fargo
California
$1.2M +$365K +57,100 +49%
AQR Capital Management
39
AQR Capital Management
Connecticut
$1.18M +$256K +39,988 +31%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.13M -$118K -18,409 -10%
Swiss National Bank
41
Swiss National Bank
Switzerland
$1.12M +$1.04M +161,900 New
AA
42
ALPS Advisors
Colorado
$1.12M +$305K +47,635 +42%
YCM
43
Yiheng Capital Management
California
$1.09M +$1.01M +157,676 New
Jane Street
44
Jane Street
New York
$1.05M +$969K +151,388 New
CC
45
Caxton Corporation
New Jersey
$933K -$370K -57,757 -30%
SCM
46
Silverarc Capital Management
Massachusetts
$899K +$832K +130,043 New
CS
47
Credit Suisse
Switzerland
$854K +$791K +123,574 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$853K +$211K +32,968 +36%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$840K
TD Asset Management
50
TD Asset Management
Ontario, Canada
$824K

ISEE Hedge Fund Activity: Q4 2020 in Review

120 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2020, worth a combined $542M — up 27% from $426M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ISEE positions and 18 closed out — a net gain of 19 holders — while 39 added to existing stakes and 28 trimmed.

The largest buyer was State Street, adding an estimated $14.4M. The largest seller was OrbiMed, exiting entirely with an estimated $19.2M sold.

  • 120 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2020, up from 101 in Q3 2020.
  • Funds reported $542M of IVERIC bio, Inc. Common Stock stock for Q4 2020, up 27% quarter-over-quarter.
  • 37 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2020 and 18 closed out, a net change of +19 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q4 2020 was State Street, an estimated $14.4M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q4 2020 was OrbiMed, an estimated $19.2M sold.

Based on aggregated 13F filings for Q4 2020.